06 Jun 2017 NIH and Themis Bioscience announce the initiation of a clinical trial of a Chikungunya vaccine
06 Jun 2017 ImmunoCellular Therapeutics Announces Data from ICT-121 Phase 1 Trial in Recurrent Glioblastoma at ASCO 2017
05 Jun 2017 Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting
05 Jun 2017 Immune Design Updates Positive Data from Lead Cancer Immunotherapy Programs at ASCO Annual Meeting
04 Jun 2017 Dendreon Announces New Findings Demonstrating Durable and Robust Killer T-Cell Response with PROVENGE
04 Jun 2017 NovaDigm Therapeutics Awarded $6 Million by U.S. Department of Defense to Conduct a Phase 2a Staphylococcus aureus Vaccine Trial
02 Jun 2017 Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combination with a PD-L1 Checkpoint Inhibitor
01 Jun 2017 Vaxon announces results of its Phase IIb lung cancer trial of Vx-001, a therapeutic vaccine based on optimized cryptic peptides
30 May 2017 European Commission Approves Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults
30 May 2017 Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes
24 May 2017 Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
23 May 2017 United Neuroscience Reports Positive Phase 1 Results for Active Vaccine UB-311 in Alzheimer’s Disease
18 May 2017 VAXIMM Announces Data from Phase I Trial in Glioblastoma with Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting
14 May 2017 Dendreon Announces Results of New PROCEED Registry Analysis Showing Overall Survival Benefit with PROVENGE® in Men with Metastatic Prostate Cancer
11 May 2017 Aimmune Therapeutics Enrolls First Patient in RAMSES (ARC007), a Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy
10 May 2017 Argos Provides Update on its ADAPT Trial Following Meeting with FDA
10 May 2017 EpiThany Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of Avelumab and EP-101 STEMVAC in Breast Cancer
09 May 2017 NantKwest and NantCell Announce FDA Authorization for the NANT Cancer Vaccine Clinical Trials, the First Novel Combination of Innate and Adaptive Immunotherapy in Patients with Pancreatic Cancer
09 May 2017 VAXIMM Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of VXM01 with Avelumab in Glioblastoma and Colorectal Cancer in Phase I/II Clinical Studies
08 May 2017 Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
04 May 2017 Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomegalovirus
03 May 2017 VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
03 May 2017 First ever evidence of treatment-induced reduction in HIV reservoirs: ABX464, ABIVAX’ lead drug candidate, impacted HIV blood reservoir in a Phase IIa clinical trial (ABX464-004)
02 May 2017 Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors
24 Apr 2017 Matinas BioPharma Presents Positive Preclinical Data of Orally Available DNA Vaccines at the 27th Annual European Congress of Clinical Microbiology and Infectious Diseases

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing